Scanfil - Not quite as high as we expected
• Scanfil Q4 revenue amounted to EUR 155m vs EUR 159m/157m Evli/consensus estimates.
• Communication top line was EUR 21m, while we estimated EUR 23m.
• Consumer Applications’ revenue was EUR 28m, compared to our EUR 27m estimate.
• Energy & Automation recorded EUR 29m Q4 revenue vs our EUR 29m estimate.
• Industrial top line amounted to EUR 47m vs our EUR 51m expectation.
• Medtec & Life Science Q4 revenue was EUR 29m, compared to our EUR 29m estimate.
• Scanfil’s Q4 EBIT stood at EUR 10.0m vs EUR 11.3m/11.0m Evli/consensus estimates. Operating margin thus amounted to 6.5%, whereas we estimated 7.1%.
• The BoD proposes EUR 0.15 (0.13) dividend per share to be distributed, which we had estimated at EUR 0.16.
• Scanfil guides ’20 revenue in the EUR 590-640m range and expects adjusted operating profit to amount to EUR 39-43m. We find this guidance range unsurprising as FY ’19 revenue stood at EUR 579.4m while adjusted operating profit was EUR 39.4m. Scanfil says the guidance is subject to exceptional uncertainty due to the coronavirus situation.
• Scanfil updates its long-term financial target, according to which Scanfil aims to reach EUR 700m revenue organically in ’23 (previously EUR 600m in ’20) with a 7% operating margin.